Effect of Pitavastatin on Coronary Fibrous-cap Thickness - Assessment by Fourier-Domain Optical Coherence Tomography (ESCORT).

Trial Profile

Effect of Pitavastatin on Coronary Fibrous-cap Thickness - Assessment by Fourier-Domain Optical Coherence Tomography (ESCORT).

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Acute coronary syndromes
  • Focus Pharmacodynamics
  • Acronyms ESCORT
  • Most Recent Events

    • 30 Aug 2017 Primary endpoint (Percent change in coronary fibrous-cap thickness) has been met as presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
    • 30 Aug 2017 Status changed from active, no longer recruiting to completed as presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
    • 30 Aug 2017 Results assessing effects of early statin therapy on fibrous cap thickness, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top